Brief: Nrx Pharmaceuticals Inc says Announced A Proposal To Simultaneously Change Cusip Under Which Company's Shares Are Traded

NRX Pharmaceuticals

12/03/2024 13:33

March 12 (Reuters) - NRX Pharmaceuticals Inc  NRXP.O :
    * NRX PHARMACEUTICALS INC - ANNOUNCED A PROPOSAL TO
SIMULTANEOUSLY
CHANGE CUSIP UNDER WHICH COMPANY'S SHARES ARE TRADED
    * NRX PHARMACEUTICALS: CONTEMPLATING REVERSE SPLIT, IF
NEEDED TO
MAINTAIN NASDAQ LISTING COMPLIANCE, TO BE ACCOMPANIED BY CHANGE
IN CORPORATE NAME
    * NRX PHARMACEUTICALS INC - ANNOUNCED A PROPOSAL TO CHANGING
NAME
OF COMPANY TO NRX THERAPEUTICS, INC
    * NRX PHARMACEUTICALS INC - PLANS TO ACCOMPANY ACTIONS WITH
A
REQUIRED EXCHANGE OF UNDERLYING STOCK CERTIFICATES
    * NRX PHARMACEUTICALS: RETAINED FORMER SEC ENFORCEMENT
LEADERSHIP
TO NOTIFY BROKERAGES OF NEED TO CLOSE ALL NAKED SHORT POSITIONS
IN CO'S SECURITIES

Source text for Eikon:  ID:nPn6LNb1Pa 
Further company coverage:  NRXP.O 

 ((Reuters.Briefs@thomsonreuters.com;))